Evidence map›Paper›PMID 33154036›Full record

ArticleDevelopment (Cambridge, England)2020

Hox13 genes are required for mesoderm formation and axis elongation during early zebrafish development.

Zhi Ye, David Kimelman

Open access · greenAbstract read
In one paragraph

Article in Development (Cambridge, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Evolvability in vertebrate segmentation.Seminars in cell & developmental biology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Science advances · 2024
    Article
  10. Article
  11. Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Review
  13. Time and space in segmentation.Interface focus · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zhi YeDepartment of Biochemistry, University of Washington, Seattle, WA 98195-7350, USA.
David KimelmanDepartment of Biochemistry, University of Washington, Seattle, WA 98195-7350, USA kimelman@uw.edu.ORCID 0000-0002-9261-4506
University of Washington · US

Funding

Regulation of Mesodermal Progenitors in Transgenic ZebrafishR01GM079203 · NIGMS · UNIVERSITY OF WASHINGTON · PI KIMELMAN, DAVID · 2008 to 2020
$4.0M
WNT REGULATION OF GENE EXPRESSIONP01GM065469 · NIGMS · UNIVERSITY OF WASHINGTON · PI KIMELMAN, DAVID · 2002 to 2005
$2.4M
NIGMS NIH HHS P01 GM065469NIGMS NIH HHS R01 GM079203
6 · The paper itself

Abstract

The early vertebrate embryo extends from anterior to posterior due to the addition of neural and mesodermal cells from a neuromesodermal progenitor (NMp) population located at the most posterior end of the embryo. In order to produce mesoderm throughout this time, the NMps produce their own niche, which is high in Wnt and low in retinoic acid. Using a loss-of-function approach, we demonstrate here that the two most abundant Hox13 genes in zebrafish have a novel role in providing robustness to the NMp niche by working in concert with the niche-establishing factor Brachyury to allow mesoderm formation. Mutants lacking both

Indexed as

AnimalsBrachyury ProteinEmbryo, NonmammalianFetal ProteinsHomeodomain ProteinsMesodermT-Box Domain ProteinsTranscription FactorsZebrafishZebrafish ProteinsBrachyury ProteinFetal ProteinsHomeodomain ProteinsHoxd13a protein, zebrafishT-Box Domain ProteinsTranscription FactorsZebrafish ProteinsBrachyuryHox genesNeuromesodermal progenitorsWnt signaling

Identifiers

PMID33154036
PMCPMC7710019
OpenAlexW3096856949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.